SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-001362
Filing Date
2019-01-22
Accepted
2019-01-22 16:48:43
Documents
3
Period of Report
2019-01-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 22378
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 15628
3 image00001.jpg GRAPHIC 3995
  Complete submission text file 0001140361-19-001362.txt   44888
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 19535776
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1